Cx46, Cx50 and Cx43 expression profiles in anterior pituitary during different periods of the annual seasonal reproductive cycle in normal male mink and during spontaneous autoimmu... by María Leiza Vitale (4287994)

“…The values shown are the mean ± SEM of three different animals per experimental condition. …”

Data_Sheet_1_A randomized double-blinded study assessing the effect of different doses of transnasal dexmedetomidine on the median effective concentration of ropivacaine for a caud... by Fu Wang (10556)

“…</p>Conclusion<p>IN-DEX decreased the EC50 of ropivacaine for the caudal block, and there was a specific dose-dependent effect for IN-DEX. …”

Fig S1. Top 50 hub genes identified in (A) module 3 (M3) and (B) module 4 (M4) based on the degree method implemented in the Cytoscape plugin cytoHubba for ranking nodes in a network by their network features.... by Gaurab Bhattarai (18542266)

Age-dependent decrease in the contribution of PMK-1 p38 MAPK signaling to <i>C. elegans</i> immunity. by Matthew J. Youngman (220485)

Linear regression analysis of decrease in viral load (VL) and trough concentrations of nevirapine (NVP C_trough). by Jia Wang (51945)

“…<p>The log transformation of decrease in viral load (dlogVL) was significantly correlated with trough nevirapine concentrations (NVP Ctrough, µg/ml) among (A) all patients (r = 0.327, <i>p</i><0.05); and (B) patients with partial response (VL 50–400 copies/ml) and virologic failure (VL>400 copies/ml) (r = 0.619, <i>p</i><0.01).…”

Move persistence estimates (γ_t) from the best-supported move persistence mixed-effects model fitted to Fastloc GPS location data from 22 naïve grey seal pups interpolate... by Benia V. R. Nowak (17054285)

<i>tho2</i> and <i>hpr1</i> selectively decrease the expression level of Rif1p. by Tai-Yuan Yu (328952)

RNAi analysis on the role of BmVg in <i>N</i>. <i>bombycis</i> TOT. by Chunxia Wang (766713)

S1 File - by Fatma Karapinar-Çarkıt (3956189)

Cost-utility analyses. by Fatma Karapinar-Çarkıt (3956189)

Flowchart of inclusion of patients. by Fatma Karapinar-Çarkıt (3956189)

Cost-effectiveness analyses for drug-related rehospitalisations. by Fatma Karapinar-Çarkıt (3956189)

Cost-effectiveness analyses for unplanned rehospitalisations. by Fatma Karapinar-Çarkıt (3956189)

Patient characteristics for usual care and the COACH program. by Fatma Karapinar-Çarkıt (3956189)

Results of adjusted cost-effectiveness and cost-utility analyses. by Fatma Karapinar-Çarkıt (3956189)

Costs used in the economic evaluation, corrected for the year 2011. by Fatma Karapinar-Çarkıt (3956189)

nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. by Peiqi Yin (6533747)

Pooled total effects and costs and differences in total effects and costs during follow-up. by Fatma Karapinar-Çarkıt (3956189)

Characterization of Niphatenones that Inhibit Androgen Receptor N-Terminal Domain by Carmen A. Banuelos (636867)

“…Both enantiomers had similar IC50 values of 6 µM for inhibiting the full-length AR in a functional transcriptional assay. …”

Usual care and COACH program components and the timeline plus measured outcomes. by Fatma Karapinar-Çarkıt (3956189)